Roivant Sciences Ltd (NASDAQ:ROIV) price on current trading day, rose 1.05% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $10.60.
A look at the stock’s price movement, the close in the last trading session was $10.49. Turning to its 52-week performance, $13.06 and $9.76 were the 52-week high and 52-week low respectively. Overall, ROIV moved -4.85% over the past month.
Roivant Sciences Ltd’s market cap currently stands at around $7.56 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 62.17M for the company’s revenue for the quarter, with a low and high estimate of 6M and 186M respectively. The average forecast suggests up to a 114.89% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 141.31M, representing a 13.24% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ROIV is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend ROIV as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ROIV’s current price about -1.39% and -5.20% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.13, while 7-day volatility ratio is 2.22% and 2.50% in the 30-day chart. Further, Roivant Sciences Ltd (ROIV) has a beta value of 1.26, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $17, forecast between a low of $12.5 and high of $17. Looking at the price targets, the low is -17.92% off current price level while to achieve the yearly target high, price needs to move -60.38%. Nonetheless, investors will most likely welcome a -60.38% jump to $17 which is the analysts’ median price.
If we refocus on Roivant Sciences Ltd (NASDAQ:ROIV), historical trading data shows that trading volumes averaged 4.41 million over the past 3 months. The company’s latest data on shares outstanding shows there are 719.63 million shares.
The 37.97% of Roivant Sciences Ltd’s shares are in the hands of company insiders while institutional holders own 68.68% of the company’s shares. Current price change has pushed the stock -10.40% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ROIV stock continues to rise going into the next quarter.
